NDRG1
Protein NDRG1 je protein koji je kod ljudi kodiran genom NDRG1.[5][6][7][8]
Ovaj gen je član N-myc porodice podreguliranih gena, koja pripada natporodici alfa/beta hidrolaza. Protein kodiran ovim genom je citoplazmatski protein koji učestvuje u odgovorima na stres, odgovorima hormona, rastu i diferencijaciji ćelija. Zabilježeno je da su mutacije u ovom genu uzročnici autosomno-recesivne verzije Charcot-Marie-Toothove bolesti, poznate kao CMT4D.[8]
Zabilježeno je da se NDRG1 lokalizira u endosomima i da je Rab4a efektor uključen u reciklažu vezikula.[9]
Prema pregledu koji su uradili Fang et al.,[10] NDRG1 je uključen u embriogenezu i razvoj, rast i diferencijaciju ćelija, biosintezu i mijelinizaciju lipida, reakcije na stres, imunost, popravak DNK i adheziju ćelija između ostalih funkcija. NDRG1 je lokaliziran u citoplazmi, jedru i mitohondrijama, s vjerovatnostima od 47,8%, odnosno 26,1% i 8,7%. Kao odgovor na oštećenje DNK, NDRG1 se prebacuje iz citoplazme u jedro, gdje može inhibirati rast ćelija i podstaknuti mehanizme popravljanja DNK. Predlaže se da NDRG1 djeluje kao gen za odgovor na stres ili potencijalno kao transkripcijski faktor.
Aminokiselinska sekvenca uredi
Dužina polipeptidnog lanca je 394 aminokiseline, а molekulska težina Da. 42 835[11]
| 10 | 20 | 30 | 40 | 50 | ||||
|---|---|---|---|---|---|---|---|---|
| MSREMQDVDL | AEVKPLVEKG | ETITGLLQEF | DVQEQDIETL | HGSVHVTLCG | ||||
| TPKGNRPVIL | TYHDIGMNHK | TCYNPLFNYE | DMQEITQHFA | VCHVDAPGQQ | ||||
| DGAASFPAGY | MYPSMDQLAE | MLPGVLQQFG | LKSIIGMGTG | AGAYILTRFA | ||||
| LNNPEMVEGL | VLINVNPCAE | GWMDWAASKI | SGWTQALPDM | VVSHLFGKEE | ||||
| MQSNVEVVHT | YRQHIVNDMN | PGNLHLFINA | YNSRRDLEIE | RPMPGTHTVT | ||||
| LQCPALLVVG | DSSPAVDAVV | ECNSKLDPTK | TTLLKMADCG | GLPQISQPAK | ||||
| LAEAFKYFVQ | GMGYMPSASM | TRLMRSRTAS | GSSVTSLDGT | RSRSHTSEGT | ||||
| RSRSHTSEGT | RSRSHTSEGA | HLDITPNSGA | AGNSAGPKSM | EVSC |
Gen uredi
Kod ljudi, gen NDRG1 nalazi se na dugom kraku hromosoma 8, sekvenca (8q24.22). Gen kodira 3,0 kilobazne (kb) informacijske RNK (iRNK) sastavljene od 394 aminokiseline. NDRG1 pripadaju porodici NDRG1, koja se sastoji od četiri člana – NDRG1, NDRG2, NDRG3 i NDRG4 – koji dijele 53-65 % homologije. Za razliku od drugih članova porodice, NDRG1 ima tri tandemska (GTRSRSHTSE) ponavljanja u C-terminalnom dijelu.[12][13]
Ekspresija NDRG1 regulirana je hipoksijom-ovisnim i neovisnim načinom. Pod hipoksijom se senzor kisika faktora induciranog hipoksijom (HIF) -1α translocira iz citoplazme u jedro, gdje se veže za HIF-1β, kako bi formirao kompleks HIF-1. Ovaj kompleks djeluje kao transkripcijski faktor, veže se na element odgovora na hipoksiju (HRE) u promotoru gena povezanih s hipoksijom; jedan od tih gena je NDRG1.[14] Ioni teških metala (nikl, kobalt, gvožđe) pojačavaju NDRG1, oponašajući hipoksiju. Suprotan učinak na ekspresiju NDRG1 mogli bi imati myc onkoproteini, N-myc i c-myc, koji transkripcijski potiskuju ekspresiju. Ovi učinci posredno se posreduju smanjenjem njegove promotorske aktivnosti.[10]
Uloga u kanceru uredi
Prema pregledu Kovačevića et al.,[15] NDRG1 je snažan supresor rasta i metastaza, reguliran gvožđem, za koji je utvrđeno da je u negativnoj korelaciji s progresijom raka u brojnim tumorima, uključujući karcinom prostate, gušterače, dojke i debelog crijeva. NDRG1 ima izrazito antionkogeno djelovanje, povezano sa smanjenom proliferacijom ćelija, migracijom, invazijom i angiogenezom. Molekulske funkcije NDRG1 utiču na brojne signalne puteve koji reguliraju proliferaciju ćelija raka, invaziju, angiogenezu i migraciju. Konkretno, NDRG1 inhibira onkogeni RAS, c-Src, fosfatidilinozitol 3-kinazu (PI3K), WNT, ROCK1/pMLC2 i jedarni faktor-pojačivač lahkog lanca puteva aktiviranih B-ćelija (NF-B), dok podstiče ekspresiju ključnog tumora – supresivne molekule uključujući fosfatazu i homolog tenzina, E-kadherin i majke protiv dekapentaplegijskog homologa 4 (SMAD4). Svojim djelovanjem na E-kadherin i beta-katenin, koji tvore adherensko spajanje i podstiču adheziju ćelija, NDRG1 također inhibira epitelno-mezenhimu tranziciju, početni ključni korak u metastaziranju.
Funkcije u popravljanju i starenju DNK uredi
U jednoj od svojih funkcija na molekulnom nivou, NDRG1 veže i stabilizira metiltransferaze, uglavnom O-6-metilguanin-DNK metiltransferaza+u (MGMT),[16] protein popravke DNK. Dakle, veća ekspresija NDRG1 može podstaknuti stabilnost i aktivnost proteina MGMT. Dominick et al.[17] pokazali su da je ekspresija proteina NDRG1 i MGMT povećana 2–3 puta za svaki od tri soja miševa (Snell, GHKRO i PAPPA-KO) s povećanom dugovječnošću. Ovi autori snažno ukazuju na vezu između povećanja puta popravljanja DNK MGMT i kašnjenja u procesu starenja ovih sojeva miša. To je u skladu s teorijom starenja oštrćenjem DNK.
Uloga u imunskom sistemu uredi
NDRG1 ima važnu ulogu u alergijama i anafilaksiji, odbrani od bakterijskih patogena i bakterijskog uklanjanja, upala i zacjeljivanja rana. U mastocitima, NDRG1 je tokom zrenja povećano reguliran i pomaže brzoj degranulaciji, što dovodi do pojačane egzocitoze, kao odgovor na različite podražaje.[18] Također je pokazana njegova uloga u klonskoj anergiji T-ćelija nizvodno od Egr2, gdje je NDRG1 pojačano reguliran u nedostatku kostimulacije, kako bi se spriječila naknadna reaktivacija T-ćelija, TCR i CD28 signalizacijom.[19]
Reference uredi
- ^ a b c GRCh38: Ensembl release 89: ENSG00000104419 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000005125 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, et al. (juli 1997). "A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms". Laboratory Investigation; A Journal of Technical Methods and Pathology. 77 (1): 85–92. PMID 9251681.
- ^ Kokame K, Kato H, Miyata T (novembar 1996). "Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes". The Journal of Biological Chemistry. 271 (47): 29659–65. doi:10.1074/jbc.271.47.29659. PMID 8939898.
- ^ Zhang J, Chen S, Zhang W, Zhang J, Liu X, Shi H, et al. (juli 2008). "Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region". Gene. 417 (1–2): 5–12. doi:10.1016/j.gene.2008.03.002. PMID 18455888.
- ^ a b "Entrez Gene: NDRG1 N-myc downstream regulated gene 1".
- ^ Kachhap SK, Faith D, Qian DZ, Shabbeer S, Galloway NL, Pili R, et al. (septembar 2007). Heisenberg C (ured.). "The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin". PLOS ONE. 2 (9): e844. Bibcode:2007PLoSO...2..844K. doi:10.1371/journal.pone.0000844. PMC 1952073. PMID 17786215.
- ^ a b Fang BA, Kovačević Ž, Park KC, Kalinowski DS, Jansson PJ, Lane DJ, et al. (januar 2014). "Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy". Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1845 (1): 1–19. doi:10.1016/j.bbcan.2013.11.002. PMID 24269900.
- ^ "UniProt, Q92597" (jezik: engleski). Pristupljeno 20. 9. 2021.
- ^ Sahni S, Park KC, Kovacevic Z, Richardson DR (juni 2019). "Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865 (6): 1361–1378. doi:10.1016/j.bbadis.2019.02.008. PMID 30763642.
- ^ Sun J, Zhang D, Bae DH, Sahni S, Jansson P, Zheng Y, et al. (septembar 2013). "Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors". Carcinogenesis. 34 (9): 1943–54. doi:10.1093/carcin/bgt163. PMID 23671130.
- ^ Park KC, Paluncic J, Kovacevic Z, Richardson DR (maj 2019). "Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer". Free Radical Biology & Medicine. 157: 154–175. doi:10.1016/j.freeradbiomed.2019.05.020. PMID 31132412.
- ^ Kovacevic Z, Menezes SV, Sahni S, Kalinowski DS, Bae DH, Lane DJ, Richardson DR (januar 2016). "The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways". The Journal of Biological Chemistry. 291 (3): 1029–52. doi:10.1074/jbc.M115.689653. PMC 4714189. PMID 26534963.
- ^ Weiler M, Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, et al. (januar 2014). "mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy". Proceedings of the National Academy of Sciences of the United States of America. 111 (1): 409–14. Bibcode:2014PNAS..111..409W. doi:10.1073/pnas.1314469111. PMC 3890826. PMID 24367102.
- ^ Dominick G, Bowman J, Li X, Miller RA, Garcia GG (februar 2017). "mTOR regulates the expression of DNA damage response enzymes in long-lived Snell dwarf, GHRKO, and PAPPA-KO mice". Aging Cell. 16 (1): 52–60. doi:10.1111/acel.12525. PMC 5242303. PMID 27618784.
- ^ Kovacevic Z, Richardson DR (decembar 2006). "The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer". Carcinogenesis. 27 (12): 2355–66. doi:10.1093/carcin/bgl146. PMID 16920733.
- ^ Oh YM, Park HB, Shin JH, Lee JE, Park HY, Kho DH, et al. (oktobar 2015). "Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2". Nature Communications. 6 (1): 8698. Bibcode:2015NatCo...6.8698O. doi:10.1038/ncomms9698. PMC 4846325. PMID 26507712.
Dopunska literatura uredi
- Kovacevic Z, Richardson DR (decembar 2006). "The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer". Carcinogenesis. 27 (12): 2355–66. doi:10.1093/carcin/bgl146. PMID 16920733.
- Maruyama K, Sugano S (januar 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Kalaydjieva L, Hallmayer J, Chandler D, Savov A, Nikolova A, Angelicheva D, et al. (oktobar 1996). "Gene mapping in Gypsies identifies a novel demyelinating neuropathy on chromosome 8q24". Nature Genetics. 14 (2): 214–7. doi:10.1038/ng1096-214. PMID 8841199. S2CID 9712904.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (oktobar 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Zhou D, Salnikow K, Costa M (maj 1998). "Cap43, a novel gene specifically induced by Ni2+ compounds". Cancer Research. 58 (10): 2182–9. PMID 9605764.
- Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW (oktobar 1998). "Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage". Cancer Research. 58 (19): 4439–44. PMID 9766676.
- Piquemal D, Joulia D, Balaguer P, Basset A, Marti J, Commes T (juli 1999). "Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1450 (3): 364–73. doi:10.1016/S0167-4889(99)00056-7. PMID 10395947.
- Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB (februar 2000). "Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer". Cancer Research. 60 (3): 749–55. PMID 10676663.
- Kalaydjieva L, Gresham D, Gooding R, Heather L, Baas F, de Jonge R, et al. (juli 2000). "N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom". American Journal of Human Genetics. 67 (1): 47–58. doi:10.1086/302978. PMC 1287101. PMID 10831399.
- Park H, Adams MA, Lachat P, Bosman F, Pang SC, Graham CH (septembar 2000). "Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells". Biochemical and Biophysical Research Communications. 276 (1): 321–8. doi:10.1006/bbrc.2000.3475. PMID 11006124.
- Rutherford MN, Bayly GR, Matthews BP, Okuda T, Dinjens WM, Kondoh H, LeBrun DP (mart 2001). "The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells". Leukemia. 15 (3): 362–70. doi:10.1038/sj.leu.2402059. PMID 11237058.
- Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, Miyata T (april 2001). "Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart". Genomics. 73 (1): 86–97. doi:10.1006/geno.2000.6496. PMID 11352569.
- Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y, He F (januar 2002). "Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family". Molecular and Cellular Biochemistry. 229 (1–2): 35–44. doi:10.1023/A:1017934810825. PMID 11936845. S2CID 24226208.
- Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M (2002). "Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis". Cell Biology and Toxicology. 18 (2): 87–96. doi:10.1023/A:1015376032736. PMID 12046693. S2CID 20827323.
- Cangul H, Salnikow K, Yee H, Zagzag D, Commes T, Costa M (oktobar 2002). "Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells". Environmental Health Perspectives. 110 Suppl 5: 783–8. doi:10.1289/ehp.02110s5783. PMC 1241245. PMID 12429530.
- Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT (novembar 2002). "Expression of NDRG1, a differentiation-related gene, in human tissues". Histochemistry and Cell Biology. 118 (5): 399–408. doi:10.1007/s00418-002-0460-9. PMID 12432451. S2CID 1599203.
- Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, et al. (decembar 2002). "Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells". Oncogene. 21 (57): 8749–58. doi:10.1038/sj.onc.1205992. PMID 12483528.
- Symes AJ, Eilertsen M, Millar M, Nariculam J, Freeman A, Notara M, et al. (2013). "Quantitative analysis of BTF3, HINT1, NDRG1 and ODC1 protein over-expression in human prostate cancer tissue". PLOS ONE. 8 (12): e84295. Bibcode:2013PLoSO...884295S. doi:10.1371/journal.pone.0084295. PMC 3874000. PMID 24386364.
